File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Three Year Efficacy and Safety of Tenofovir Alafenamide (TAF) Compared to Tenofovir Disoproxil Fumarate (TDF) in Hbeag-Negative and Hbeag-Positive Patients with Chronic Hepatitis B

TitleThree Year Efficacy and Safety of Tenofovir Alafenamide (TAF) Compared to Tenofovir Disoproxil Fumarate (TDF) in Hbeag-Negative and Hbeag-Positive Patients with Chronic Hepatitis B
Authors
Chan, HLYLim, YSSeto, WKWAgarwal, KBrunetto, MRJanssen, HLACaruntu, FStepanova, TTsang, OYatsuhashi, HTak, WYChen, CYCelen, MSun, VFlaherty, JFLin, LCathcart, AGaggar, APan, CQShalimarButi, M
Issue Date2018
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/
Citation
The Liver Meeting 2018, American Association for the Study of Liver Diseases (AASLD), San Francisco, USA, 9-13 November 2018. Abstracts in Hepatology, 2018, v. 68 n. Suppl. 1, p. 227A-228A How to Cite?
DescriptionPoster Presentation - no. 381
Persistent Identifierhttp://hdl.handle.net/10722/269514
ISSN
0270-9139
2021 Impact Factor: 17.298
2020 SCImago Journal Rankings: 5.488

 

DC FieldValueLanguage
dc.contributor.authorChan, HLY-
dc.contributor.authorLim, YS-
dc.contributor.authorSeto, WKW-
dc.contributor.authorAgarwal, K-
dc.contributor.authorBrunetto, MR-
dc.contributor.authorJanssen, HLA-
dc.contributor.authorCaruntu, F-
dc.contributor.authorStepanova, T-
dc.contributor.authorTsang, O-
dc.contributor.authorYatsuhashi, H-
dc.contributor.authorTak, WY-
dc.contributor.authorChen, CY-
dc.contributor.authorCelen, M-
dc.contributor.authorSun, V-
dc.contributor.authorFlaherty, JF-
dc.contributor.authorLin, L-
dc.contributor.authorCathcart, A-
dc.contributor.authorGaggar, A-
dc.contributor.authorPan, CQ-
dc.contributor.authorShalimar-
dc.contributor.authorButi, M-
dc.date.accessioned2019-04-24T08:09:15Z-
dc.date.available2019-04-24T08:09:15Z-
dc.date.issued2018-
dc.identifier.citationThe Liver Meeting 2018, American Association for the Study of Liver Diseases (AASLD), San Francisco, USA, 9-13 November 2018. Abstracts in Hepatology, 2018, v. 68 n. Suppl. 1, p. 227A-228A-
dc.identifier.issn0270-9139-
dc.identifier.urihttp://hdl.handle.net/10722/269514-
dc.descriptionPoster Presentation - no. 381-
dc.languageeng-
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/-
dc.relation.ispartofHepatology-
dc.relation.ispartofAmerican Association for the Study of Liver Diseases (AASLD): The Liver Meeting 2018-
dc.titleThree Year Efficacy and Safety of Tenofovir Alafenamide (TAF) Compared to Tenofovir Disoproxil Fumarate (TDF) in Hbeag-Negative and Hbeag-Positive Patients with Chronic Hepatitis B-
dc.typeConference_Paper-
dc.identifier.emailSeto, WKW: wkseto@hku.hk-
dc.identifier.authoritySeto, WKW=rp01659-
dc.identifier.hkuros297390-
dc.identifier.volume68-
dc.identifier.issueSuppl. 1-
dc.identifier.spage227A-
dc.identifier.epage228A-
dc.publisher.placeUnited States-
dc.identifier.issnl0270-9139-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats